| Trial Identifier: | ACE-CL-002 |
| Sponsor: | AcertaPharma |
| NCTID: | NCT02157324 |
| Start Date: | August 2014 |
| Primary Completion Date: | July 2020 |
| Study Completion Date: | December 2025 |
| Condition: | CLL (Chronic Lymphocytic Leukemia) |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| US, TN | Hermitage, TN, US, 37076 |
| US, TX | Fort Worth, TX, US, 76104 |
| US, OH | Columbus, OH, US, 43210 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2023 Pharma Intelligence UK Limited (Citeline), a Norstella company